Emerging nutrition science on fatty acids and cardiovascular disease: nutritionists' perspectives.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 25979506)

Published in Adv Nutr on May 15, 2015

Authors

Penny M Kris-Etherton1, Jennifer A Fleming2

Author Affiliations

1: Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA pmk3@psu.edu.
2: Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA.

Articles cited by this

Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med (2013) 20.98

U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, January 2011. Adv Nutr (2011) 19.32

Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44

Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA (2012) 9.37

Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet (1994) 9.13

Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation (1999) 8.13

n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med (2010) 7.58

Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA (2005) 6.89

Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr (2003) 6.83

Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67

Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med (2012) 5.84

Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02

A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med (2009) 4.80

Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med (2010) 4.79

A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr (2000) 4.38

Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med (2006) 4.16

Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr (1999) 3.91

Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ (2013) 3.78

Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation (2009) 3.23

Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr (2001) 3.12

n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr (2010) 3.09

Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation (2014) 2.95

Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. Int J Epidemiol (1979) 2.79

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation (2012) 2.72

Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study. Circulation (2014) 2.63

Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ (2012) 2.59

Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med (2010) 2.48

Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev (2012) 2.47

Comparison of the effects of medium-chain triacylglycerols, palm oil, and high oleic acid sunflower oil on plasma triacylglycerol fatty acids and lipid and lipoprotein concentrations in humans. Am J Clin Nutr (1997) 2.21

Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias? A meta-analysis of randomized trials. Heart Lung (2013) 1.97

Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis (2007) 1.78

Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids (2010) 1.75

Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids (2010) 1.70

Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction. Eur Heart J (2012) 1.67

The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am J Clin Nutr (2011) 1.66

Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids (2011) 1.63

Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr (2012) 1.60

Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res (2009) 1.55

α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr (2012) 1.48

Dietary fat and serum lipids: an evaluation of the experimental data. Am J Clin Nutr (1993) 1.44

Biomarker-calibrated energy and protein consumption and cardiovascular disease risk among postmenopausal women. Epidemiology (2011) 1.37

Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab (2009) 1.36

Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am J Clin Nutr (2010) 1.31

Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation (2005) 1.28

Omega-6 polyunsaturated fatty acids and coronary heart disease. Am J Clin Nutr (2009) 1.24

Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes (2012) 1.21

Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid. Am J Clin Nutr (2008) 1.21

Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr (2008) 1.17

Dietary prevention of coronary heart disease in women: the Finnish mental hospital study. Int J Epidemiol (1983) 1.15

Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J Nutr (2001) 1.15

Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence. Altern Ther Health Med (2005) 1.14

Monounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence available from systematic reviews and meta-analyses. Nutrients (2012) 1.07

Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial. Nutrition (2007) 1.05

Estimating the cardiovascular mortality burden attributable to the European Common Agricultural Policy on dietary saturated fats. Bull World Health Organ (2008) 1.05

Dietary fats, teas, dairy, and nuts: potential functional foods for weight control? Am J Clin Nutr (2005) 1.05

Amino acids, arginase and nitric oxide in vascular health. Clin Exp Pharmacol Physiol (2006) 1.03

Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. J Nutr (2009) 1.02

Dietary fat quality and risk of sudden cardiac death in women. Am J Clin Nutr (2012) 1.02

Effects of margarine containing medium-chain triacylglycerols on body fat reduction in humans. J Atheroscler Thromb (2003) 1.01

Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr (2007) 1.01

A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study. J Clin Lipidol (2012) 1.00

Modification of plant lipids for human health: development of functional land-based omega-3 fatty acids. J Nutr (2003) 0.98

Changes in blood lipids during six days of overfeeding with medium or long chain triglycerides. J Lipid Res (1990) 0.98

Omega-3 fatty acids and cardiovascular disease: new developments and applications. Postgrad Med (2013) 0.97

Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2008) 0.96

A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers. J Am Coll Nutr (2008) 0.95

Medium-chain fatty acids as metabolic therapy in cardiac disease. Cardiovasc Drugs Ther (2008) 0.95

Effects of monounsaturated fatty acids on cardiovascular risk factors: a systematic review and meta-analysis. Ann Nutr Metab (2011) 0.94

Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected]. Atheroscler Suppl (2013) 0.93

Fish oil and post-operative atrial fibrillation: a meta-analysis of randomized controlled trials. J Am Coll Cardiol (2013) 0.87

Stearidonic acid-enhanced soybean oil: a plant-based source of (n-3) fatty acids for foods. J Nutr (2012) 0.87

DHA-enriched high-oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trial. Am J Clin Nutr (2014) 0.86

N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc (2013) 0.86

Incorporation of (n-3) fatty acids in foods: challenges and opportunities. J Nutr (2012) 0.85

Effect of ALA-enriched food supply on cardiovascular risk factors in males. Lipids (2009) 0.83

Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study. Vasc Health Risk Manag (2013) 0.83

Plasma lipids and lipoproteins during 6 d of maintenance feeding with long-chain, medium-chain, and mixed-chain triglycerides. Am J Clin Nutr (1992) 0.81

Plasma phospholipid and dietary α-linolenic acid, mortality, CHD and stroke: the Cardiovascular Health Study. Br J Nutr (2014) 0.81

Prevention of sudden cardiac death: lessons from recent controlled trials. Circ J (2005) 0.80

Influence of the dietary intake of medium chain triglycerides on body composition, energy expenditure and satiety: a systematic review. Nutr Hosp (2012) 0.80

Dietary medium-chain triglyceride supplementation has no effect on apolipoprotein B-48 and apolipoprotein B-100 kinetics in insulin-resistant men. Am J Clin Nutr (2013) 0.78

Dietary protein intake and risk of stroke in women. Atherosclerosis (2012) 0.77

Dietary fat composition and cardiac events in patients with type 2 diabetes. Atherosclerosis (2014) 0.77